March 2 (www.haiwainet.cn)- On Monday (March 1) local time, a scientific committee set up by Hamad Hassan, Minister of Public Health of Lebanon Caretaker Cabinet, approved the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd. (BIBP), China National Biotec GroupCompany Limited(CNBG), Sinopharm (BIBP’s COVID-19 ...
View More +On February 17 local time, the Department of Drug Administration of Nepal issued a notice to approve the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd.(BIBP), China National Biotec Group Company Limited (CNBG), Sinopharm (BIBP’s COVID-19 Vaccine) for emergency use. According to...
View More +On February 25, 2021, the Ministry of Health (MOH) of Seychelles officially approved the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd. (BIBP), China National Biotec Group Company Limited (CNBG), Sinopharm (BIBP’s COVID-19 Vaccine) for registration and marketing in Seychelles, making Seychelles the fou...
View More +Inactivated COVID-19 Vaccine (Vero Cell) of Beijing Institute of Biological Products Müller Cecília, Chief Medical Officer of Hungary, announced at a press conference on January 29 that, Hungary’s drug regulator gave use approval to the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., ...
View More +Approved for Emergency Use in Iraq The Iraqi National Regulatory Authority has approved the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd. (BIBP), China National Biotec Group Company Limited (CNBG), Sinopharm (“BIBP’s COVID-19 Vaccine”) for emergency use, as reported by Iraqi media on J...
View More +